Assays &Synthesis &sequencing

  • Published 2004 in Nature Biotechnology

Abstract

The first in a line of fixed-content genotyping products is available from Illumina. Based on a new assay and Sentrix BeadChip configuration, the line of microarrays will allow largescale interrogation of variation in the human genome at many levels of resolution, increasing researchers’ ability to cost-effectively unlock the genetic basis of disease. The first product will target at least 100,000 SNPs located in high-value genetic regions of human genome. The new assay targets the growing market opportunity for fixed-content genotyping and complements the GoldenGate custom genotyping assay. http://www.illumina.com/ N E W O N T H E M A R K E T

DOI: 10.1038/nbt0804-1031

Cite this paper

@article{2004Assays, title={Assays &Synthesis &sequencing}, author={}, journal={Nature Biotechnology}, year={2004}, volume={22}, pages={1031-1033} }